Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
05/2001
05/31/2001WO1999062923A3 Immunostimulatory oligonucleotides with modified bases and methods of use thereof
05/31/2001WO1999028462A9 Polypeptides and nucleic acids encoding the same
05/30/2001EP1102863A1 Mutations in and genomic structure of herg - a long qt syndrome gene
05/30/2001EP1102862A1 Antisense oligonucleotides targeted to il-15
05/30/2001EP1102842A2 Antisense oligonucleotides for the inhibition of vegf expression
05/30/2001EP1102787A1 2'-o-aminoethyloxyethyl-modified oligonucleotides
05/30/2001EP1102786A2 Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments
05/30/2001EP1102785A1 COMPOSITIONS AND METHODS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES
05/30/2001EP1102784A1 A compound containing a labile disulfide bond
05/30/2001EP1102783A1 Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom
05/30/2001EP1102781A1 New cofactors for methyltransferases
05/30/2001EP0920526A4 Covalent joining of dna strands to rna strands catalyzed by vaccinia topoisomerase
05/30/2001EP0662093B1 Hiv immunotherapeutics
05/30/2001EP0620822B1 Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
05/30/2001CN1297452A Modified factor VIII
05/30/2001CN1296976A Polypeptide-human epidermal growth factor receptor protein 25 and polynucleotide for coding said polypeptide
05/30/2001CN1296972A Polypeptide-human myosin heavy chain 74 and polynucleotide for coding said polypeptide
05/30/2001CN1296971A Polypeptide-huntingtin protein interactive protein 65 and polynucleotide for coding said polypeptide
05/30/2001CN1296969A Polypeptide-human X chromosome linked gene expression protein 14 and polynucleotide for coding said polypeptide
05/30/2001CN1296965A Polypeptide-human fibrous growth factor receptor 46 and polynucleotide for coding said polypeptide
05/30/2001CN1296963A Polypeptide-human vascular epithelium cadherin 54 and polynucleotide for coding said polypeptide
05/30/2001CN1296961A Polypeptide-human CDC4 analogous protein 13 and polynucleotide for coding said polypeptide
05/30/2001CN1296960A Polypeptide-human CCR4 related protein 31 and polynucleotide for coding said polypeptide
05/30/2001CN1296958A Polypeptide-human G protein 44 and polynucleotide for coding said polypeptide
05/30/2001CN1296955A Human susceptible protein and its coding sequence
05/30/2001CN1296954A Human membrane protein containing C2 structural domain and its coding sequence
05/30/2001CN1296952A Polypeptide-complement receptor 222 and polynucleotide for coding said polypeptide
05/30/2001CN1066486C Riboflavinover producing strains of bacteria
05/30/2001CN1066456C Oligonucleotides having 2'-ether groups
05/29/2001US6239273 Printing molecular library arrays
05/29/2001US6239272 Oligonucleotide having one or more modified nucleotides of defined structure; antisense agents; ribozymes
05/29/2001US6239271 Solid matrix with immoblized intercalator capable of binding nucleic acid, another intercalator which may be labeled with fluorophore, and nucleic acid probe labeled with lanthanide or fluorophore; time resolved fluorescence hybridization
05/29/2001US6239265 Oligonucleotides having chiral phosphorus linkages
05/29/2001US6239256 Isolated muteins of proteins SCP-1, and compositions containing the mutein
05/29/2001US6239159 Nucleoside analogues
05/29/2001US6239116 Immunostimulatory nucleic acid molecules
05/29/2001US6238927 Hybridizing probe to tether nucleic acid which has been immobilized to electrophoretic polymeric medium, migrating test nucleic acid through medium and hybridizing with probe causing displacement of tether, detecting probe-target hybrid
05/29/2001US6238921 Antisense oligonucleotide modulation of human mdm2 expression
05/29/2001US6238898 Hydroperoxide lyases
05/29/2001US6238884 End selection in directed evolution
05/29/2001US6238875 Immunoassay diagnosis of chronic lymphocytic leukemia in humans by detecting and quantitating gene expression of effector cell protease receptors on cd5 positive sample cells
05/29/2001US6238870 Single stranded nucleic acid labeled with electron transfer moiety and attached to electrode by a three-dimensional polymer matrix; bioconductors and diagnostic probes
05/29/2001US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins
05/29/2001US6238624 A self-addressable, self-assembling microelectronic device is designed and fabricated to actively carry out and control multi-step and multiplex molecular biological reactions in microscopic formats.
05/29/2001CA2325278A1 Nucleic acid-immobilized substrate
05/29/2001CA2171638C The semaphorin gene family
05/29/2001CA2127530C Metal complexes of water soluble texaphyrins
05/25/2001WO2001037191A2 Method for manipulating protein or dna sequence data (in order to generate complementary peptide ligands)
05/25/2001WO2001036677A1 Development of method for screening physiologically active pyrrole imidazole derivative
05/25/2001WO2001036585A1 Sequence tag microarray and method for detection of multiple proteins through dna methods
05/25/2001WO2001036473A2 Human g protein-coupled receptors
05/25/2001WO2001036441A1 Antisense modulation of src-3 expression
05/25/2001WO2001036439A2 Method for constructing oligodesoxyribonucleotide binomial libraries with codon mutagenized using desoxynucleoside-phosphoramitides
05/25/2001WO2001036086A1 Method for producing finished chemical surfaces
05/25/2001CA2391999A1 Method for constructing oligodesoxyribonucleotide binomial libraries with codon mutagenized using desoxynucleoside-phosphoramitides
05/25/2001CA2388865A1 Novel g protein-coupled receptors
05/23/2001EP1100973A1 Oligomers which inhibit expression of collagen genes
05/23/2001EP1100972A1 Reversible inhibiting probes
05/23/2001EP1100894A2 Short oligonucleotides for the inhibition of vegf expression
05/23/2001EP1100889A1 Micellar systems
05/23/2001EP1100886A1 Tumor necrosis factor-gamma
05/23/2001EP1100880A2 Urate oxidase
05/23/2001EP1100815A1 Protease susceptibility ii
05/23/2001EP1100809A1 Rna targeted 2'-modified oligonucleotides that are conformationally preorganized
05/23/2001EP1100807A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS
05/23/2001EP0815259B1 Modulation of the binding properties of nucleic acid binding partners
05/23/2001CN1296014A Novel human growth arrestin and coding sequence thereof
05/22/2001US6235887 Measurement, calibration of oligonucleotide binding to nucleic acids
05/22/2001US6235886 Methods of synthesis and use
05/22/2001US6235885 Central nervous system disorders
05/22/2001US6235723 Antisense oligonucleotide modulation of human protein kinase C-δ expression
05/22/2001US6235502 Methods for selectively isolating DNA using rolling circle amplification
05/22/2001US6235475 Generating nucleotide sequence probes; generate nucleotide sequences, compare to library of nucleotide sequences, retain and synthesize preferential nucleotide sequences
05/22/2001US6235470 Detection of neoplasia by analysis of saliva
05/22/2001US6235266 Dinucleotides useful for the treatment of lung disease
05/17/2001WO2001034845A1 Method for quantitating oligonucleotides
05/17/2001WO2001034827A1 Antisense modulation of rank expression
05/17/2001WO2001034765A1 Methods and apparatus for the electronic, homogeneous assembly and fabrication of devices
05/17/2001WO2001034624A1 Methods for identifying compounds that affect rna/rna binding protein interactions
05/17/2001WO2001034620A2 Method and device for producing oligomers and arrays of oligomers and the use of said device
05/17/2001WO2001034619A1 2-aminopurine derivatives
05/17/2001WO2001034207A1 Gene carriers
05/17/2001WO2001021635A3 Method for electrochemically detecting sequence-specific nucleic acid-oligomer hybridisation events
05/17/2001WO2001007602A3 Oligonucleotides for inhibiting the expression of human eg5
05/17/2001WO2001002593A3 Control of gene expression in eukaryotic cells
05/17/2001WO2000075306A3 Method for producing double stranded polynucleotides
05/17/2001WO1999044620A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
05/17/2001CA2391004A1 Method for quantitating oligonucleotides
05/17/2001CA2390233A1 2-aminopurine derivatives
05/17/2001CA2382348A1 Methods for identifying compounds that affect rna/rna binding protein interactions
05/16/2001EP1098990A1 Blocked-polymerase polynucleotide immunoassay method and kit
05/16/2001EP1098966A1 Methods for purifying nucleic acids
05/16/2001EP1023310A4 Improved synthesis of sulfurized oligonucleotides
05/16/2001EP0927270A4 Lyophilization of cultured human cells to preserve rna and dna
05/16/2001EP0753009B1 Malaria peptides
05/16/2001EP0643721B1 Method of synthesizing sulfurized oligonucleotide analogs
05/16/2001CN1295611A Substrates for immobilizing and amplifying DNA DNA-immobilized chips having DNA immobilized on the substrates, and method for amplifying DNA
05/16/2001CN1295078A Antisense thio-oligonucleic acid of target protein kinase C-alpha and its medicine composition and application in treating cancer
05/16/2001CN1065873C Decorative primer
05/15/2001US6232465 Nucleotide 5'-triphosphate having a removable blocking moiety protecting the 3' position and linked to the 3' carbon which is a hydrocarbyl, so a single phosphodiester linkage is formed between the initiating substrate and 5' nucleotide